Novel immunotherapy drug to treat GBM « Charlie Teo Foundation

Novel immunotherapy drug to treat GBM

16 July 2024

A team of investigators led by Amy Heimberger, MD, PhD, just published new findings in the Journal of Clinical Investigation!

Charlie Teo Foundation is proud to have supported this groundbreaking research through a AU$500,000 Better Tools grant at Northwestern University, USA.

Charlie Teo Foundation Better Tools Investigator Amy Heimberger, MD, PhD
The Heimberger Lab, in collaboration with Charlie Teo Foundation funded investigators Prof Irina Balyasnikova and Prof Craig Horbinski, discovered that using a novel drug to target the STING pathway in glioblastoma reprogrammed previously suppressed immune responses. This type of immunotherapy was shown to significantly enhance survival in preclinical models of Glioblastoma. This therapy is now being considered for clinical translation.
 
 
Find out more about this Charlie Teo Foundation Grant


Congratulations to Amy Heimberger’s Lab for their unwavering commitment to advancing brain cancer research!